130 related articles for article (PubMed ID: 1017468)
1. [Cerebrovascular disorders : facial thermography as a means to evaluate the therapeutic effectiveness of nicergoline].
Sbarbaro V; Zardini GB; Morgante R; Mora L; Acciarri L; Pistolesi GF
Farmaco Prat; 1976 Nov; 31(11):549-60. PubMed ID: 1017468
[No Abstract] [Full Text] [Related]
2. [The role of nicergoline in the symptomatic treatment of arterial hypertension and chronic cerebrovascular insufficiency. A study on 359 observations (author's transl)].
Dauverchain J
Arzneimittelforschung; 1979; 29(8a):1308-10. PubMed ID: 395956
[TBL] [Abstract][Full Text] [Related]
3. [Trial of nicergoline in arteriopathies of the lower limbs (apropos of 33 cases)].
Debaert M; Ribet M; Quandalle P
Lille Med; 1981 Mar; 26(3):140-3. PubMed ID: 7289750
[No Abstract] [Full Text] [Related]
4. [Clinico-rheographic study of the cerebrovascular effect of alpha-adrenergic blockers in vascular diseases of the brain].
Shtok VN; Varlamova IV; Fedorova NV; Timurbaator
Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(9):1333-8. PubMed ID: 4072531
[TBL] [Abstract][Full Text] [Related]
5. [The effect of pentoxifylline and nicergoline on the systemic and cerebral hemodynamics and on the blood rheological properties in patients with an ischemic stroke and atherosclerotic lesions of the major cerebral arteries].
Gara II
Zh Nevrol Psikhiatr Im S S Korsakova; 1993; 93(3):28-32. PubMed ID: 8042384
[TBL] [Abstract][Full Text] [Related]
6. [Neurophysiological study of 36 patients with cerebral vascular processes treated with nicergoline (author's transl)].
Samsó Dies JM; Villa Badó J; Villalobos J; Iriarte JL; Ordeix R
Arzneimittelforschung; 1979; 29(8a):1301-7. PubMed ID: 540075
[TBL] [Abstract][Full Text] [Related]
7. [Psychopathometric double blind study with nicergoline versus placebo in geriatric patients with slight transit syndromes].
Blaha L; Burkard G; Lehrl S; Kapinas K
Arzneimittelforschung; 1979; 29(8a):1295-301. PubMed ID: 395955
[TBL] [Abstract][Full Text] [Related]
8. [Initial dyscirculatory encephalopathy in middle-aged and elderly patients (problems of early diagnosis and therapy)].
Man'kovskiĭ NB; Mints AIa; Karaban' IN
Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(1):16-20. PubMed ID: 2718657
[TBL] [Abstract][Full Text] [Related]
9. [Value of nicergoline in postischemic cerebral resuscitation. An experimental study in the dog].
Cahn R; Weber S; Angignard J; Angignard D; Borzeix MG
Agressologie; 1987 Mar; 28(3):341-6. PubMed ID: 3618895
[No Abstract] [Full Text] [Related]
10. [Electroencephalography and psychometric measurements during the treatment of cerebral insufficiency with nicergoline and dihydroergotamine mesylate].
Kugler JE; Meurer-Krüll BC
Arzneimittelforschung; 1985; 35(12):1865-70. PubMed ID: 3913425
[TBL] [Abstract][Full Text] [Related]
11. [Buflomedil and nicergoline in the targeted treatment of acute cerebral ischemia. Randomized comparative double blind study].
Bossi L
Minerva Med; 1985 May; 76(21):1005-18. PubMed ID: 3889723
[TBL] [Abstract][Full Text] [Related]
12. [Intravenous effect of nicergoline in arterial hypertension].
Levenson JA; Roland E; Toto Mou Kouo J; Simon A; Safar M
Rev Med Interne; 1980; 1(1):123-6. PubMed ID: 7232904
[No Abstract] [Full Text] [Related]
13. Clinical study on nicergoline in peripheral arteriopathies.
Schönenberger F
Farmaco Prat; 1976 Nov; 31(11):561-7. PubMed ID: 797575
[No Abstract] [Full Text] [Related]
14. [The effect of nicergoline on the systemic and cerebral hemodynamics of patients with circulatory encephalopathy and an atherosclerotic lesion of the major cerebral arteries].
Ishchenko MM; Shkrobot SI
Lik Sprava; 1992 Oct; (10):100-2. PubMed ID: 1485425
[TBL] [Abstract][Full Text] [Related]
15. [Effectiveness of nicergoline in the treatment of chronic cerebrovascular insufficiency (author's transl)].
Kaemmerer E
Nervenarzt; 1980 Jun; 51(6):368-72. PubMed ID: 7453888
[No Abstract] [Full Text] [Related]
16. [Effect of nicergoline on the intellectual performance (author's transl)].
Donoso A; Santander M; Sarce H
Rev Med Chil; 1979 Sep; 107(9):817-9. PubMed ID: 396627
[No Abstract] [Full Text] [Related]
17. [Action of Nicergoline (Sermion) in chronic vascular disease in old age].
Michelangeli J; Sevilla M; Lavagna J; Darcourt G
Ann Med Psychol (Paris); 1975 Apr; 1(4):499-510. PubMed ID: 788599
[No Abstract] [Full Text] [Related]
18. [Clinical efficacy of nicergoline in cerebrovascular diseases. Statistical study].
Guardamagna C; Negri S
Minerva Cardioangiol; 1972 Nov; 20(11):636-41. PubMed ID: 4566130
[No Abstract] [Full Text] [Related]
19. [Therapeutic activity of nicergoline in cerebrovascular syndromes].
Toni E
Minerva Med; 1973 Nov; 64(84):4466-73. PubMed ID: 4771472
[No Abstract] [Full Text] [Related]
20. [Clinical and electroencephalographic studies of the effect of nicergoline in cerebrovascular diseases].
Montanini R; Gasco P; Manfredini G
Acta Neurol (Napoli); 1973; 28(2):133-49. PubMed ID: 4575428
[No Abstract] [Full Text] [Related]
[Next] [New Search]
